Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription 29.04.2024 1 Acad Emerg Med 1 Antiviral Res 3 BMJ 2 Clin Infect Dis 8 Emerg Infect Dis 1 Infect Control Hosp Epidemiol 1 Int J Infect Dis 1 J Infect 3 J Med Virol 2 J Virol 8 JAMA 2 Lancet 3 Lancet Infect Dis 1 Life Sci 2 MMWR Morb Mortal Wkly Rep 3 N Engl J Med 1 Nature 2 Radiologia (Engl Ed) 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acad Emerg Med

1. PAXTON JH, Keenan KJ, Wilburn JM, Wise SL, et al
   Headpulse measurement can reliably identify large-vessel occlusion stroke in prehospital suspected stroke patients: Results from the EPISODE-PS-COVID study.
   Acad Emerg Med. 2024 Apr 21. doi: 10.1111/acem.14919.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. GLITSCHER M, Benz NI, Sabino C, Murra RO, et al
   Inhibition of Pim kinases triggers a broad antiviral activity by affecting innate immunity and via the PI3K-Akt-mTOR axis the endolysosomal system.
   Antiviral Res. 2024;226:105891.
   PubMed         Abstract available
   
   

   
   BMJ

3. 
   Seven days in medicine: 17-23 April 2024.
   BMJ. 2024;385:q924.
   PubMed        
   
   
4. KANG D
   The ever looming shadow of caregiving.
   BMJ. 2024;385:q726.
   PubMed        
   
   
5. LAUNER J
   John Launer: Doctors as activists.
   BMJ. 2024;385:q939.
   PubMed        
   
   

   
   Clin Infect Dis

6. CHUA KP, Fischer MA, Rahman M, Linder JA, et al
   Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the Coronavirus Disease 2019 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data.
   Clin Infect Dis. 2024 Apr 22:ciae135. doi: 10.1093.
   PubMed         Abstract available
   
   
7. VASCONCELOS A, King JD, Nunes-Alves C, Anderson R, et al
   Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?
   Clin Infect Dis. 2024;78.
   PubMed         Abstract available
   
   

   
   Emerg Infect Dis

8. OPE M, Musyoka R, Kiogora J, Wambugu J, et al
   Epidemiology of SARS-CoV-2 in Kakuma Refugee Camp Complex, Kenya, 2020-2021(1).
   Emerg Infect Dis. 2024;30:900-907.
   PubMed         Abstract available
   
   
9. NOBLE BA, Jiudice SS, Jones JD, Timbrook TT, et al
   Reemergence of Bordetella parapertussis, United States, 2019-2023.
   Emerg Infect Dis. 2024;30:1058-1060.
   PubMed         Abstract available
   
   
10. YEE R, Carranza D, Kim C, Trinidad JP, et al
    COVID-19 Vaccination Site Accessibility, United States, December 11, 2020-March 29, 2022.
    Emerg Infect Dis. 2024;30:947-955.
    PubMed         Abstract available
    
    
11. KEHOE AD, Mallhi AK, Barton CR, Martin HM, et al
    SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020-January 2022.
    Emerg Infect Dis. 2024;30:956-967.
    PubMed         Abstract available
    
    
12. MOUCHTOURI VA, Kourentis L, Anagnostopoulos L, Koureas M, et al
    Interventional Study of Nonpharmaceutical Measures to Prevent COVID-19 Aboard Cruise Ships.
    Emerg Infect Dis. 2024;30:1030-1033.
    PubMed         Abstract available
    
    
13. LUSTIG Y, Canetti M, Indenbaum V, Peretz Y, et al
    SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.
    Emerg Infect Dis. 2024;30:1050-1052.
    PubMed         Abstract available
    
    
14. NGUYENLA XH, Bates TA, Trank-Greene M, Wahedi M, et al
    Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 Vaccine.
    Emerg Infect Dis. 2024;30.
    PubMed         Abstract available
    
    
15. DOI A, Ota M, Saito M, Matsuyama S, et al
    Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.
    Emerg Infect Dis. 2024;30.
    PubMed         Abstract available
    
    

    
    Infect Control Hosp Epidemiol

16. TAN C, Chan CK, Ofner M, O'Brien J, et al
    Implementation of point-of-care molecular testing for respiratory viruses in congregate living settings.
    Infect Control Hosp Epidemiol. 2024 Apr 25:1-5. doi: 10.1017/ice.2024.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

17. VERGORI A, Cozzi-Lepri A, Tavelli A, Mazzotta V, et al
    SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T cell counts in people living with HIV.
    Int J Infect Dis. 2024 Apr 19:107065. doi: 10.1016/j.ijid.2024.107065.
    PubMed         Abstract available
    
    

    
    J Infect

18. ZHOU J, Lan L, Ai S, Lin J, et al
    Corrigendum to: "People living with HIV who have poor immune status are a key population for SARS-CoV-2 prevention" Journal of Infection, Volume 88, Issue 3, March 2024, 106122.
    J Infect. 2024 Apr 24:106157. doi: 10.1016/j.jinf.2024.106157.
    PubMed        
    
    

    
    J Med Virol

19. HSU AY, Lin CJ, Hsia NY, Wang YH, et al
    Reply to comment on "The risk assessment of uveitis after COVID-19 diagnosis by Wu et al. 2024".
    J Med Virol. 2024;96:e29636.
    PubMed        
    
    
20. HEWEL C, Schmidt H, Runkel S, Kohnen W, et al
    Nanopore adaptive sampling of a metagenomic sample derived from a human monkeypox case.
    J Med Virol. 2024;96:e29610.
    PubMed         Abstract available
    
    
21. SONG G, Li R, Cheng MQ
    Safety, immunogenicity, and protective effective of inhaled COVID-19 vaccines: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e29625.
    PubMed         Abstract available
    
    

    
    J Virol

22. VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
    Harnessing the power of IFN for therapeutic approaches to COVID-19.
    J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
    PubMed         Abstract available
    
    
23. MAO D, Liu S, Phan AT, Renner S, et al
    The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
    J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
    PubMed         Abstract available
    
    

    
    JAMA

24. HARRIS E
    Antidepressant Prescriptions for Female Teens Surged After Pandemic.
    JAMA. 2024;331:1266.
    PubMed        
    
    
25. BARNELL EK, Lieberman DA
    Multitarget Stool RNA Testing-Reply.
    JAMA. 2024;331:1419-1420.
    PubMed        
    
    
26. BAIRD G
    Multitarget Stool RNA Testing.
    JAMA. 2024;331:1418-1419.
    PubMed        
    
    
27. IMPERIALE TF, Lavin P, Ransohoff DF
    Multitarget Stool RNA Testing.
    JAMA. 2024;331:1418.
    PubMed        
    
    
28. HARRIS E
    Deaths From Excessive Drinking Rose in the US During Pandemic.
    JAMA. 2024;331:1355.
    PubMed        
    
    
29. HARRIS E
    Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
    JAMA. 2024;331:1355.
    PubMed        
    
    
30. ALLEN MR, Desai N, Namazi A, Leas E, et al
    Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
    JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
    PubMed        
    
    
31. HARRIS E
    WHO Launches Broad Coronavirus Surveillance Network.
    JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724.
    PubMed        
    
    

    
    Lancet

32. DEVI S
    Swedish NGOs are reeling after government cuts.
    Lancet. 2024;403:1527.
    PubMed        
    
    
33. 
    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

34. JIN SL, Kolis J, Parker J, Proctor DA, et al
    Social histories of public health misinformation and infodemics: case studies of four pandemics.
    Lancet Infect Dis. 2024 Apr 19:S1473-3099(24)00105.
    PubMed         Abstract available
    
    
35. ZUO W, He D, Liang C, Du S, et al
    The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China.
    Lancet Infect Dis. 2024 Apr 22:S1473-3099(24)00171.
    PubMed         Abstract available
    
    
36. BUONSENSO D, Tantisira KG
    Long COVID and SARS-CoV-2 persistence: new answers, more questions.
    Lancet Infect Dis. 2024 Apr 22:S1473-3099(24)00216.
    PubMed        
    
    

    
    Life Sci

37. LI Q, Peng G, Liu H, Wang L, et al
    Molecular mechanisms of secretory autophagy and its potential role in diseases.
    Life Sci. 2024 Apr 23:122653. doi: 10.1016/j.lfs.2024.122653.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

38. PANAGIOTAKOPOULOS L, Godfrey M, Moulia DL, Link-Gelles R, et al
    Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged >/=65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:377-381.
    PubMed         Abstract available
    
    
39. SMITH-JEFFCOAT SE, Mellis AM, Grijalva CG, Talbot HK, et al
    SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:365-371.
    PubMed         Abstract available
    
    

    
    N Engl J Med

40. MOSER CB, Li JZ, Hughes MD
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1533-1534.
    PubMed        
    
    
41. SELVI-SABATER P, de la Rubia Orti JE, Urbieta-Sanz E
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1534.
    PubMed        
    
    
42. WANG Y, Hu H, Cao B
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply.
    N Engl J Med. 2024;390:1534-1535.
    PubMed        
    
    

    
    Nature

43. NOGRADY B
    WHO redefines airborne transmission: what does that mean for future pandemics?
    Nature. 2024 Apr 24. doi: 10.1038/d41586-024-01173.
    PubMed        
    
    

    
    Radiologia (Engl Ed)

44. PLASENCIA MARTINEZ JM, Garcia Tuells I, Bravo Perez C, Blanco Barrio A, et al
    Target sign in COVID-19, radiological interpretation and diagnostic contribution of digital thoracic tomosynthesis.
    Radiologia (Engl Ed). 2024;66 Suppl 1:S32-S39.
    PubMed         Abstract available
    
    
45. VALENZUELA C, de la Fuente L, Hernandez S, Olivera MJ, et al
    Persistent pulmonary abnormalities after 18 months of SARS-CoV-2 pneumonia.
    Radiologia (Engl Ed). 2024;66 Suppl 1:S47-S56.
    PubMed         Abstract available
    
    

    
    Science

46. COHEN J
    Africa steps up battle against mpox outbreaks.
    Science. 2024;384:373-374.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.